Youmanitarian 11 Jun 2021

التالي

تشغيل تلقائي

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman

uchetex · 13 المشاهدات

Defining Progression in Metastatic Kidney Cancer

0

0

10 المشاهدات

TAKE ACTION

Donations would go to support charities for كيف تصمم

في كيف تصمم

Panelists Robert A. Figlin, MD; Michael R. Harrison, MD; David I. Quinn, MBBS, PhD; and Eric Jonasch, MD, discuss defining clinical progression and optimizing use of VEGF TKI therapy to achieve the highest dose intensity before switching in patients with metastatic kidney cancer.

أظهر المزيد

More ways to take action

Explore ways that you can help bring a solution to this issue.

Create Youms with
hashtags كيف تصمم

Create a challenge to
bring awareness to this issue for people to complete

Create a fundraiser to
support a charity that tackle this issue

Volunteer at charitable organization
that support this cause

Create a movement page dedicated to this cause to bring awareness.

Start a uCharity for this cause and invite people to join it to support this cause

التالي

تشغيل تلقائي

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman

uchetex · 13 المشاهدات

الصفحة الرئيسية

الاقسام